SYNA Form 4: Director awarded 3,036 RSUs, ownership now 40,977

Rhea-AI Filing Summary

Synaptics (SYNA) disclosed a Form 4 showing a director acquired 3,036 shares of common stock on 11/03/2025 from a restricted stock unit grant at a stated price of $0. Following the transaction, the director beneficially owns 40,977 shares directly.

The award vests in equal quarterly installments, with one-fourth of the RSUs vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. This reflects routine director equity compensation and a time-based vesting schedule.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Geeslin Keith

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,036	$0.00	--

Holdings After Transaction: Common Stock — 40,977 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geeslin Keith

(Last) (First) (Middle)

C/O FRANCISCO PARTNERS

ONE LETTERMAN DRIVE, BLDG. C, STE. 410

(Street)

SAN FRANCISCO CA 94129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		A		3,036(1)	A	$0	40,977	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.

Remarks:

	/s/ Pamela Fields, as attorney-in-fact	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Synaptics (SYNA) report in this Form 4?

A director acquired 3,036 shares via RSUs on 11/03/2025 at a stated price of $0, bringing direct beneficial ownership to 40,977 shares.

How do the RSUs for SYNA’s director vest?

One-fourth of the RSUs vests each quarter until fully vested on November 3, 2026, or for a director not standing for re-election, on the date of the 2026 Annual Meeting.

What is the director’s ownership in SYNA after the transaction?

Direct beneficial ownership is 40,977 shares after the reported transaction.

What was the transaction price for the acquired SYNA shares?

The reported price for the acquired shares was $0, consistent with RSU settlements.

What role does the reporting person have at SYNA?

The reporting person is a Director of Synaptics.

Is this SYNA filing indicative of a sale or purchase on the open market?

No. It reflects RSU acquisition per a compensation grant with scheduled vesting.